% alzhub.org topic: semaglutide
% Source: https://alzhub.org/topic/semaglutide
% 9 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{dasilva2026-41825212,
  author  = {da Silva, A. M. P. and Januário Campos Cardoso, L. and Batista, S. and Gonçalves, O. R. and Paranhos, T. and Teixeira, I. P. S. and Guimarães, P. D. and Espinosa Franco, B. and others},
  title   = {{Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study}},
  journal = {Journal of diabetes and its complications},
  year    = {2026},
  doi     = {10.1016/j.jdiacomp.2026.109306},
  pmid    = {41825212},
  url     = {https://doi.org/10.1016/j.jdiacomp.2026.109306}
}

@article{scheltens2026-41522368,
  author  = {Scheltens, P. and Atri, A. and Feldman, H. H. and Zetterberg, H. and Sano, M. and Johannsen, P. and Colombo, T. L. and Bardtrum, L. and others},
  title   = {{Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2026},
  doi     = {10.1002/trc2.70200},
  pmid    = {41522368},
  url     = {https://doi.org/10.1002/trc2.70200}
}

@article{evola2026-41504939,
  author  = {Evola, V. and Parmar, M. S.},
  title   = {{Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide}},
  journal = {Inflammation research : official journal of the European Histamine Research Society ... [et al.]},
  year    = {2026},
  doi     = {10.1007/s00011-025-02166-6},
  pmid    = {41504939},
  url     = {https://doi.org/10.1007/s00011-025-02166-6}
}

@article{alkhatib2025-40904035,
  author  = {Alkhatib, M. and Almasri, N. and Alshwayyat, S. and Almahariq, H. and Hammadeh, B. M. and Taimeh, Z. and Alkhatib, L. and Alshwayat, A. and others},
  title   = {{The multifaceted effects of semaglutide: exploring its broad therapeutic applications}},
  journal = {Future science OA},
  year    = {2025},
  doi     = {10.1080/20565623.2025.2483607},
  pmid    = {40904035},
  url     = {https://doi.org/10.1080/20565623.2025.2483607}
}

@article{sabbagh2025-40337158,
  author  = {Sabbagh, M. and Boschini, C. and Cohen, S. and Fugger, M. and Jessen, F. and Dandanell, S. and Pedersen, S. D. and Tarazona, L. R. S. and others},
  title   = {{Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2025},
  doi     = {10.1002/trc2.70076},
  pmid    = {40337158},
  url     = {https://doi.org/10.1002/trc2.70076}
}

@article{boboc2024-39767596,
  author  = {Boboc, I. K. S. and Dumitrelea, P. D. and Meca, A. D. and Mititelu-Tartau, L. and Bogdan, M.},
  title   = {{Exploring the Impact of Semaglutide on Cognitive Function and Anxiety-Related Behaviors in a Murine Model of Alzheimer's Disease}},
  journal = {Biomedicines},
  year    = {2024},
  doi     = {10.3390/biomedicines12122689},
  pmid    = {39767596},
  url     = {https://doi.org/10.3390/biomedicines12122689}
}

@article{wang2024-39547338,
  author  = {Wang, Z. J. and Han, W. N. and Chai, S. F. and Li, Y. and Fu, C. J. and Wang, C. F. and Cai, H. Y. and Li, X. Y. and others},
  title   = {{Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP/PS1/tau mice}},
  journal = {Neuroscience},
  year    = {2024},
  doi     = {10.1016/j.neuroscience.2024.11.022},
  pmid    = {39547338},
  url     = {https://doi.org/10.1016/j.neuroscience.2024.11.022}
}

@article{wang2024-39445596,
  author  = {Wang, W. and Wang, Q. and Qi, X. and Gurney, M. and Perry, G. and Volkow, N. D. and Davis, P. B. and Kaelber, D. C. and others},
  title   = {{Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.14313},
  pmid    = {39445596},
  url     = {https://doi.org/10.1002/alz.14313}
}

@article{meca2024-38921025,
  author  = {Meca, A. D. and Boboc, I. K. S. and Mititelu-Tartau, L. and Bogdan, M.},
  title   = {{Unlocking the Potential: Semaglutide's Impact on Alzheimer's and Parkinson's Disease in Animal Models}},
  journal = {Current issues in molecular biology},
  year    = {2024},
  doi     = {10.3390/cimb46060354},
  pmid    = {38921025},
  url     = {https://doi.org/10.3390/cimb46060354}
}